Federal
Register Notices > Notices
of Registration - 2008 >
Roche Diagnostics
Operation, Inc
FR Doc E8-2141 [Federal Register: February 6, 2008 (Volume
73, Number 25)] [Notices] [Page 7004] From the Federal Register
Online via GPO Access [wais.access.gpo.gov] [DOCID:fr06fe08-85]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated March 22, 2007 and published in the Federal
Register on March 29, 2007, (72 FR 14832), Roche Diagnostics
Operation, Inc., Attn: Regulatory Compliance, 9115 Hauge Road,
Indianapolis, Indiana 46250, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as an
importer of the basic classes of controlled substances listed in
schedules I and II:
Drug
|
Schedule
|
Lysergic acid diethylamide (7315)
|
I
|
Alphamethadol (9605)
|
I
|
Tetrahydrocannabinols (7370)
|
I
|
Cocaine (9041)
|
II
|
Ecgonine (9180)
|
II
|
Methadone (9250)
|
II
|
Morphine (9300)
|
II
|
The company plans to import the listed controlled substances
for the manufacture of diagnostic products for distribution to
its customers.
No comments or objections have been received. DEA has
considered the factors in 21
U.S.C. 823(a) and 952(a) and
determined that the registration of Roche Diagnostics
Operations, Inc. to import the basic class of controlled
substance is consistent with the public interest and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has
investigated Roche Diagnostics Operations, Inc. to ensure that
the company's registration is consistent with the public
interest. The investigation has included inspection and testing
of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of
the company's background and history. Therefore, pursuant to 21
U.S.C. 952(a) and 958(a), and in accordance with
21 CFR
1301.34,
the above named company is granted registration as an importer
of the basic class of controlled substances listed.
Dated: January 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement Administration.
[FR Doc. E8-2141 Filed 2-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|